[1. S. H. Giordano, D. S. Cohen, A. U. Buzdar, G. Perkins and G. N. Hortobagyi, Breast carcinoma in men: a population-based study, Cancer: Interdisc. Int. J. Am. Cancer Soc.101 (2004) 51–57; https://doi.org/10.1002/cncr.2031210.1002/cncr.2031215221988]Search in Google Scholar
[2. L. W. C. Chow, A. Yun-San Yip, W. T. Y. Loo and M. Toi, Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer, Cancer Lett. 262 (2008) 232–238; https://doi.org/10.1016/j.canlet.2007.12.00310.1016/j.canlet.2007.12.00318248884]Search in Google Scholar
[3. A. M. Farag, A. S. Mayhoub, T. M. Eldebss, A. G. E. Amr, K. A. Ali, N. A. Abdel-Hafez and M. M. Abdulla, Synthesis and structure-activity relationship studies of pyrazole-based heterocycles as antitumor agents, Arch. Pharm. 343 (2010) 384–396; https://doi.org/10.1002/ardp.20090017610.1002/ardp.20090017620397210]Search in Google Scholar
[4. Z. Sahin, M. Ertas, B. Berk, S.N. Biltekin, L. Yurttas and S. Demirayak, Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl) thiazole derivatives, Bioorg. Med. Chem.26 (2018) 1986–1995; https://doi.org/10.1016/j.bmc.2018.02.04810.1016/j.bmc.2018.02.04829525337]Search in Google Scholar
[5. R. J. Santen, E. Samojlik, A. Lipton, H. Harvey, E. B. Ruby, S. A. Wells and J. Kendall, Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer, Cancer39 (1977) 2948–2958; https://doi.org/10.1002/1097-0142(197706)39:6<2948::AID-CNCR2820390681 >3.0.CO;2-9]Search in Google Scholar
[6. R. J. Santen, S. Santner, B. Davis, J. Veldhuis, E. Samojlik and E. Ruby, Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma, J. Clin. Endocrinol. Metab.47 (1978) 1257–1265; https://doi.org/10.1210/jcem-47-6-125710.1210/jcem-47-6-1257263348]Search in Google Scholar
[7. M. Ertas, Z. Sahin, B. Berk, L. Yurttas, S.N. Biltekin and S. Demirayak, Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation, Arch. Pharm.351 (2018) 1700272; https://doi.org/10.1002/ardp.20170027210.1002/ardp.20170027229522642]Search in Google Scholar
[8. P. Furet, C. Batzl, A. Bhatnagar, E. Francotte, G. Rihs and M. Lang, Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds, J. Med. Chem.36 (1993) 1393–1400.]Search in Google Scholar
[9. C. D. Jones, M. A. Winter, K. S. Hirsch, N. Stamm, H. M. Taylor, H. E. Holden, J. D. Davenport, E. V. Krumkalns and R. G. Suhr, Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups, J. Med. Chem.33 (1990) 416–429.10.1021/jm00163a0652296032]Search in Google Scholar
[10. A. Cavalli and M. Recanatini, Looking for selectivity among cytochrome P450s inhibitors, J. Med. Chem. 45 (2002) 251–254; https://doi.org/10.1021/jm015567k10.1021/jm015567k11784128]Search in Google Scholar
[11. M. L. Fascio, C. S. Sepúlveda, E. B. Damonte and N. B. D’Accorso, Synthesis and antiviral activity of some imidazo [1,2-b][1,3,4] thiadiazole carbohydrate derivatives, Carbohydr. Res.480 (2019) 61–66; https://doi.org/10.1016/j.carres.2019.05.00310.1016/j.carres.2019.05.00331176191]Search in Google Scholar
[12. J. Chen, C. Yi, S. Wang, S. Wu, S. Li, D. Hu and B. Song, Novel amide derivatives containing 1,3,4-thiadiazole moiety: Design, synthesis, nematocidal and antibacterial activities, Bioorg. Med. Chem. Lett. 29 (2019) 1203–12010; https://doi.org/10.1016/j.bmcl.2019.03.01710.1016/j.bmcl.2019.03.01730902458]Search in Google Scholar
[13. G. Serban, Future prospects in the treatment of parasitic diseases: 2-Amino-1,3,4-thiadiazoles in leishmaniasis, Molecules24 (2019) 1557–1579; https://doi.org/10.3390/molecules2408155710.3390/molecules24081557651467331010226]Search in Google Scholar
[14. D. C. Sekhar, D. V. Rao, A. T. Rao, U. L. Kumar and A. Jha, Design and synthesis of 1,3,4-thiadiazole derivatives as novel anticancer and antitubercular agents, Russ. J. Gen. Chem.89 (2019) 770–779; https://doi.org/10.1134/S107036321904022410.1134/S1070363219040224]Search in Google Scholar
[15. A. Foroumadi, Z. Kargar, A. Sakhteman, Z. Sharifzadeh, R. Feyzmohammadi, M. Kazemi and A. Shafiee, Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio] propionates, Bioorg. Med. Chem. Lett.16 (2006) 1164–1167; https://doi.org/10.1016/j.bmcl.2005.11.08710.1016/j.bmcl.2005.11.08716359863]Search in Google Scholar
[16. B. Sharma, A. Verma, S. Prajapati and U. K. Sharma, Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles, Int. J. Med. Chem.2013 (2013) Article ID 348948 (16 pages); https://doi.org/10.1155/2013/34894810.1155/2013/348948420745625405032]Search in Google Scholar
[17. V. Mathew, J. Keshavayya, V. P. Vaidya and D. Giles, Studies on synthesis and pharmacological activities of 3, 6-disubstituted-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles and their dihydro analogues, Eur. J. Med. Chem.42 (2007) 823–840; https://doi.org/10.1016/j.ejmech.2006.12.01010.1016/j.ejmech.2006.12.01017331622]Search in Google Scholar
[18. İ. Celik, G. Ayhan-Kılcıgil, B. Guven, Z. Kara, A. S. Gurkan-Alp, A. Karayel and A. Onay-Besikci, Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors, Eur. J. Med. Chem.173 (2019) 240–249; https://doi.org/10.1016/j.ejmech.2019.04.01210.1016/j.ejmech.2019.04.01231009910]Search in Google Scholar
[19. M. F. Abo-Ashour, W. M. Eldehna, A. Nocentini, H. S. Ibrahim, S. Bua, H. A. Abdel-Aziz, S. M. Abou-Seri and C. T. Supuran, Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies, Bioorg. Chem.87 (2019) 794–802; https://doi.org/10.1016/j.bioorg.2019.04.00210.1016/j.bioorg.2019.04.00230978604]Search in Google Scholar
[20. D. I. Pérez, M. Pistolozzi, V. Palomo, M. Redondo, C. Fortugno, C. Gil, G. Felix, A. Martinez and C. Bertucci, 5-Imino-1,2,4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood–brain barrier penetration and binding to human serum albumin, Eur. J. Pharm. Sci.45 (2012) 677–684; https://doi.org/10.1016/j.ejps.2012.01.00710.1016/j.ejps.2012.01.00722306656]Search in Google Scholar
[21. Y. Bahmani, T. Bahrami and A. Alabadi, Synthesis, cytotoxicity assessment and molecular docking of n-(5-(substituted-benzylthio)-1,3,4-thiadiazole-2-yl)-2-p-fluorophenylacetamide derivatives as tyrosine kinase inhibitors, Indian J. Pharm. Sci. 81 (2019) 63–70.10.4172/pharmaceutical-sciences.1000480]Search in Google Scholar
[22. A. S. Mayhoub, L. Marler, T. P. Kondratyuk, E. J. Park, J. M. Pezzuto and M. Cushman, Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets, Bioorg. Med. Chem.20 (2012) 510–520; https://doi.org/10.1016/j.bmc.2011.09.03110.1016/j.bmc.2011.09.031324895822115839]Search in Google Scholar
[23. M. Varache-Lembege, S. Moreau, S. Larrouture, D. Montaudon, J. Robert and A. Nuhrich, Synthesis and antiproliferative activity of aryl- and heteroaryl-hydrazones derived from xanthone carbaldehydes, Eur. J. Med. Chem.43 (2008) 1336–1343; https://doi.org/10.1016/j.ejmech.2007.09.00310.1016/j.ejmech.2007.09.003]Search in Google Scholar
[24. M. V. Berridge, P. M. Herst and A. S. Tan, Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction, Biotechnol. Annu. Rev.11 (2005) 127–152; https://doi.org/10.1016/S1387-2656(05)11004-710.1016/S1387-2656(05)11004-7]Search in Google Scholar
[25. Ü. Demir Özkay, Ö. D. Can, B. N. Sağlık, U. Acar Çevik, S. Levent, Y. Özkay, S. Ilgın and Ö. Atlı, Design, synthesis, and AChE inhibitory activity of new benzothiazole–piperazines, Bioorg. Med. Chem. Lett.26 (2016) 5387–5394; https://doi.org/10.1016/j.bmcl.2016.10.04110.1016/j.bmcl.2016.10.04127789142]Search in Google Scholar
[26. M. R. Haider, K. Ahmad, N. Siddiqui, Z. Ali, M. J. Akhtar, N. Fuloria, S. Fuloria, M. Ravichandran and M. S. Yar, Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target topoisomerase 1 and growth inhibition of HeLa cancer cells, Bioorg. Chem. 88 (2019) Article ID 102962; https://doi.org/10.1016/j.bioorg.2019.10296210.1016/j.bioorg.2019.10296231085373]Search in Google Scholar